Reports - Cancer Biomarkers Market
Biotechnology and Life SciencesCancer Biomarkers Market
Cancer Biomarkers Market Size and Projected Growth Through 2035 by Biomarkers Type (Protein Biomarkers, Genetic Biomarkers, Other), by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer), by Profiling Technologies (Omics Technologies, Imaging Technologies, Immunoassay, Bioinformatics), by Application (Research & Development, Prognostics, Risk Assessment, Others), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Cancer Biomarkers Market - Segment Analysis
1. Overview
2. Global Cancer Biomarkers Market, 2021 - 2035 (USD Million)
3. Global Cancer Biomarkers Market - by Biomarkers Type
3.1. By Protein Biomarkers
3.2. By Genetic Biomarkers
3.3. By Others
4. Global Cancer Biomarkers Market - by Cancer Type
4.1. By Breast Cancer
4.2. By Lung Cancer
4.3. By Colorectal Cancer
4.4. By Prostate Cancer
4.5. By Melanoma
4.6. By Leukemia
4.7. By Thyroid Cancer
4.8. By Bladder Cancer
4.9. By Non-Hodgkins Lymphoma Kidney Cancer
4.10. By Others
5. Global Cancer Biomarkers Market - by Profiling Technologies
5.1. By Omics Technologies
5.2. By Imaging Technologies
5.3. By Immunoassay
5.4. By Bioinformatics
5.5. By Cytogenetics
6. Global Cancer Biomarkers Market - by Application
6.1. By Research & Development
6.2. By Prognostics
6.3. By Risk Assessment
6.4. By Others
7. Global Cancer Biomarkers Market - by region
7.1. North America
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Market comparative analysis
Chapter 4 North America Cancer Biomarkers Market - Segment Analysis
1. Overview
2. North America Cancer Biomarkers Market, 2021 - 2035 (USD Million)
3. North America Cancer Biomarkers Market - by Biomarkers Type
3.1. By Protein Biomarkers
3.2. By Genetic Biomarkers
3.3. By Others
4. North America Cancer Biomarkers Market - by Cancer Type
4.1. By Breast Cancer
4.2. By Lung Cancer
4.3. By Colorectal Cancer
4.4. By Prostate Cancer
4.5. By Melanoma
4.6. By Leukemia
4.7. By Thyroid Cancer
4.8. By Bladder Cancer
4.9. By Non-Hodgkins Lymphoma Kidney Cancer
4.10. By Others
5. North America Cancer Biomarkers Market - by Profiling Technologies
5.1. By Omics Technologies
5.2. By Imaging Technologies
5.3. By Immunoassay
5.4. By Bioinformatics
5.5. By Cytogenetics
6. North America Cancer Biomarkers Market - by Application
6.1. By Research & Development
6.2. By Prognostics
6.3. By Risk Assessment
6.4. By Others
Chapter 5 Europe Cancer Biomarkers Market - Segment Analysis
1. Overview
2. Europe Cancer Biomarkers Market, 2021 - 2035 (USD Million)
3. Europe Cancer Biomarkers Market - by Biomarkers Type
3.1. By Protein Biomarkers
3.2. By Genetic Biomarkers
3.3. By Others
4. Europe Cancer Biomarkers Market - by Cancer Type
4.1. By Breast Cancer
4.2. By Lung Cancer
4.3. By Colorectal Cancer
4.4. By Prostate Cancer
4.5. By Melanoma
4.6. By Leukemia
4.7. By Thyroid Cancer
4.8. By Bladder Cancer
4.9. By Non-Hodgkins Lymphoma Kidney Cancer
4.10. By Others
5. Europe Cancer Biomarkers Market - by Profiling Technologies
5.1. By Omics Technologies
5.2. By Imaging Technologies
5.3. By Immunoassay
5.4. By Bioinformatics
5.5. By Cytogenetics
6. Europe Cancer Biomarkers Market - by Application
6.1. By Research & Development
6.2. By Prognostics
6.3. By Risk Assessment
6.4. By Others
Chapter 6 Asia Pacific Cancer Biomarkers Market - Segment Analysis
1. Overview
2. Asia Pacific Cancer Biomarkers Market, 2021 - 2035 (USD Million)
3. Asia Pacific Cancer Biomarkers Market - by Biomarkers Type
3.1. By Protein Biomarkers
3.2. By Genetic Biomarkers
3.3. By Others
4. Asia Pacific Cancer Biomarkers Market - by Cancer Type
4.1. By Breast Cancer
4.2. By Lung Cancer
4.3. By Colorectal Cancer
4.4. By Prostate Cancer
4.5. By Melanoma
4.6. By Leukemia
4.7. By Thyroid Cancer
4.8. By Bladder Cancer
4.9. By Non-Hodgkins Lymphoma Kidney Cancer
4.10. By Others
5. Asia Pacific Cancer Biomarkers Market - by Profiling Technologies
5.1. By Omics Technologies
5.2. By Imaging Technologies
5.3. By Immunoassay
5.4. By Bioinformatics
5.5. By Cytogenetics
6. Asia Pacific Cancer Biomarkers Market - by Application
6.1. By Research & Development
6.2. By Prognostics
6.3. By Risk Assessment
6.4. By Others
Chapter 7 Latin America Cancer Biomarkers Market - Segment Analysis
1. Overview
2. Latin America Cancer Biomarkers Market, 2021 - 2035 (USD Million)
3. Latin America Cancer Biomarkers Market - by Biomarkers Type
3.1. By Protein Biomarkers
3.2. By Genetic Biomarkers
3.3. By Others
4. Latin America Cancer Biomarkers Market - by Cancer Type
4.1. By Breast Cancer
4.2. By Lung Cancer
4.3. By Colorectal Cancer
4.4. By Prostate Cancer
4.5. By Melanoma
4.6. By Leukemia
4.7. By Thyroid Cancer
4.8. By Bladder Cancer
4.9. By Non-Hodgkins Lymphoma Kidney Cancer
4.10. By Others
5. Latin America Cancer Biomarkers Market - by Profiling Technologies
5.1. By Omics Technologies
5.2. By Imaging Technologies
5.3. By Immunoassay
5.4. By Bioinformatics
5.5. By Cytogenetics
6. Latin America Cancer Biomarkers Market - by Application
6.1. By Research & Development
6.2. By Prognostics
6.3. By Risk Assessment
6.4. By Others
Chapter 8 Middle East & Africa Cancer Biomarkers Market - Segment Analysis
1. Overview
2. Middle East & Africa Cancer Biomarkers Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Cancer Biomarkers Market - by Biomarkers Type
3.1. By Protein Biomarkers
3.2. By Genetic Biomarkers
3.3. By Others
4. Middle East & Africa Cancer Biomarkers Market - by Cancer Type
4.1. By Breast Cancer
4.2. By Lung Cancer
4.3. By Colorectal Cancer
4.4. By Prostate Cancer
4.5. By Melanoma
4.6. By Leukemia
4.7. By Thyroid Cancer
4.8. By Bladder Cancer
4.9. By Non-Hodgkins Lymphoma Kidney Cancer
4.10. By Others
5. Middle East & Africa Cancer Biomarkers Market - by Profiling Technologies
5.1. By Omics Technologies
5.2. By Imaging Technologies
5.3. By Immunoassay
5.4. By Bioinformatics
5.5. By Cytogenetics
6. Middle East & Africa Cancer Biomarkers Market - by Application
6.1. By Research & Development
6.2. By Prognostics
6.3. By Risk Assessment
6.4. By Others
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. F. Hoffmann-La Roche Ltd. (Switzerland)
2. Thermo Fisher Scientific Inc. (US)
3. Qiagen N.V. (Netherlands)
4. Illumina Inc. (US)
5. Bio-Rad Laboratories Inc. (US)
6. Abbott Laboratories (US)
7. Bio Mérieux SA (US)
8. Becton-Dickinson and Company (US)
9. Merck Millipore (US)
10. Agilent Technologies (US)
11. Myriad Genetics Inc. (US)
12. Sysmex Corporation (Japan)
13. Hologic Inc. (US)
14. Quest Diagnostics (US)
15. Centogene N.V. (Germany)
16. PerkinElmer Inc. (US)
17. Siemens Healthineers (Germany)
18. Exact Sciences (US)
19. R&D Systems Inc. (US)
20. BioVision Inc. (US)
21. Olink (Sweden)
22. Asuragen Inc. (US)
23. Meso Scale Diagnostics LLC (US)
24. Invivoscribe Inc. (US)
25. Seegene Technologies Inc. (South Korea)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By